Skip to main content
LIFECORE BIOMEDICAL, INC. \DE\ logo

LIFECORE BIOMEDICAL, INC. \DE\ — Investor Relations & Filings

Ticker · LFCR ISIN · US5147661046 LEI · 549300EHBZ5OM9ND9O43 US Manufacturing
Filings indexed 1,095 across all filing types
Latest filing 2026-05-06 Interim / Quarterly Rep…
Country US United States of America
Listing US LFCR

About LIFECORE BIOMEDICAL, INC. \DE\

https://www.lifecore.com/

Lifecore Biomedical is an integrated contract development and manufacturing organization (CDMO) that specializes in sterile injectable pharmaceutical drug products and medical devices. The company provides a full range of services, including specialty formulation, process development, aseptic filling, and final packaging, supporting products from clinical phases through to commercial supply. A key area of expertise is the handling of complex and highly viscous formulations. In addition to its CDMO capabilities, Lifecore is a primary producer of non-animal-sourced sodium hyaluronate (hyaluronic acid), offering it in various molecular weights and formats, including bulk material, hydrogels, and filled syringes and vials for diverse applications.

Recent filings

Filing Released Lang Actions
10-Q - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
Interim / Quarterly Report
2026-05-06 English
8-K - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
Regulatory Filings
2026-05-06 English
4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
Director's Dealing
2026-03-03 English
8-K Filing
Regulatory Filings
2026-01-16 English
8-K
Regulatory Filings
2025-11-17 English
10-Q
Interim / Quarterly Report Q1 2025
2025-11-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.